Sodium phenylacetate and Sodium benzoate
Sodium phenylacetate and Sodium benzoate is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Sodium phenylacetate and Sodium benzoate; Generic name: SODIUM PHENYLACETATE AND SODIUM BENZOATE; Manufacturer: Zydus Pharmaceuticals USA Inc..
| Brand name | Sodium phenylacetate and Sodium benzoate |
|---|---|
| Generic name | SODIUM PHENYLACETATE AND SODIUM BENZOATE |
| Manufacturer | Zydus Pharmaceuticals USA Inc. |
| Used for | 1 INDICATIONS AND USAGE Sodium Phenylacetate and Sodium Benzoate Injection is a nitrogen binding agent indicated as adjunctive therapy for the treatment of acute hyperammonemia and associated encephalopathy in paediatric and adult patients with deficiencies in enzymes of the urea cycle. ( 1 ) Sodium Phenylacetate and Sodium Benzoate Injection is indicated as adjunctive therapy in pediatric and adult patients for the treatment of acute hyperammonemia and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle. During acute hyperammonemic episodes, arginine supplementation, caloric supplementation, dietary protein restriction, hemodialysis, and other ammonia loweri |
| Dosage | 2 DOSAGE AND ADMINISTRATION Sodium Phenylacetate and Sodium Benzoate Injection must be diluted with sterile 10% Dextrose Injection (D10W) before administration. Administration must be through a central venous catheter. Administration through a peripheral line may cause burns. ( 2 ) Sodium Phenylacetate and Sodium Benzoate Injection is administered intravenously as a loading dose infusion administered over 90 to 120 minutes, followed by an equivalent maintenance dose infusion administered over 24 |
| Active ingredient(s) | SODIUM BENZOATE |
| Route | INTRAVENOUS |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0f17c50f-3761-4470-bf3b-63837a287b8a |